Focus Stocks
Emerson near Resistance
Published on Wednesday, 08 February 2012 07:00 Written by TradersHuddle Wire
New York, February 8th (TradersHuddle.com) - Shares of Emerson Electric Co. (NYSE:EMR) are trading very close to calculated resistance at $53.78 with the current price action closing at just $51.92 placing the stock near levels that make it difficult to buy.
Emerson Electric Co. (NYSE:EMR) manufactures and markets electrical, electromechanical, and electronic products and systems. The Company produces a variety of products, including process control, industrial automation, electronics, appliance components, and electric motors. The company was founded in 1890 and is based in St. Louis, Missouri.
Emerson's current stock range is defined by current calculated support defined at $45.00 and by the resistance level at $53.78, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for Emerson, as the stock is well above support, however, as the stock pulls back towards $45.00 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $53.78 then traders will get an opportunity to enter Emerson stock by establishing a position as the stock moves to a higher range.
Related Articles
- Will Emerson recover?
- Is Emerson Resistance Ahead?
- Emerson is Near a Key Support Area
- Trading Idea: Entry Levels for Emerson
- Emerson Process Management Wins Strategic Account Management Program of the Year Award
- Close to Key Levels: Emerson
- Emerson Declares Dividend
- Reference Points for Emerson
- Stock Futures Mixed amid Earnings. Stocks to Watch: APC, AAPL, BAC, BIIB, BP, EMR, F, MAS, PFE
- Emerson Reports Second Quarter 2012 Results
Related Partner Headlines
- Emerson Electric Co. (EMR): Today's Featured Industrial Goods Winner - TheStreet.com
- Emerson Electric Co. (EMR): Today's Featured Industrial Goods Loser - TheStreet.com
- Emerson Electric Stock To Go Ex-dividend Tomorrow (EMR) - TheStreet.com
- Emerson Electric Co. (EMR): Today's Featured Industrial Loser - TheStreet.com
- UPDATE: Credit Suisse Cuts PT to $53 on Emerson; Valuation - Benzinga
- Emerson Electric Down 6% on Weak Earnings, Guidance - Benzinga
- UPDATE: Emerson Electric Posts Drop In Q2 Profit - Benzinga
- Emerson Electric Co. (EMR): Today's Featured Industrial Winner - TheStreet.com
- Dusting Off My Watch List - TheStreet.com
- Hello, Ruby Tuesday - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









